1. 1) Estimates for 2000-2015: cause-specific mortality. Available at: http://www.who.int/healthinfo/global_burden_disease/ estimates/en/index1.html. Accessed August 01, 2018
2. 2) Population Survey Report 2016. Available at: http://www. mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei16/dl/10_h6. pdf. Accessed August 01, 2018
3. 3) Japan Atherosclerosis Society: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases, Japan Atherosclerosis Society, Tokyo, 2017
4. 4) Reiner Z, Catapano A L, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, and Wood D: ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European atherosclerosis Society (EAS). Eur Heart J, 2011; 32: 1769-1818
5. 5) Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members: An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemiaefull report. J Clin Lipidol, 2014; 8: 29-60